SNSE
NASDAQ · Biotechnology
Sensei Biotherapeutics Inc
$8.86
-0.04 (-0.45%)
Open$8.65
Previous Close$8.90
Day High$9.07
Day Low$8.65
52W High$32.42
52W Low$21.16
Volume—
Avg Volume438.5K
Market Cap11.18M
P/E Ratio—
EPS$0.27
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+225.5% upside
Current
$8.86
$8.86
Target
$28.84
$28.84
$22.09
$28.84 avg
$40.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.00M | 5.90M | 5.57M |
| Net Income | -817,172 | -706,875 | -767,435 |
| Profit Margin | -13.6% | -12.0% | -13.8% |
| EBITDA | -1,135,758 | -954,399 | -978,652 |
| Free Cash Flow | -597,971 | -436,320 | -559,358 |
| Rev Growth | +2.3% | +18.9% | +16.5% |
| Debt/Equity | 0.18 | 0.16 | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |